GYRE THERAPEUTICS INC COM - Stock (CBIO)

CUSIP: 14888D208

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / Stock
Total 13F shares
1,254,597
Share change
+101,392
Total reported value
$6,339,000
Price per share
$5.04
Number of holders
10
Value change
+$539,581
Number of buys
5
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 14888D208?
CUSIP 14888D208 identifies CBIO - GYRE THERAPEUTICS INC COM - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GYRE THERAPEUTICS INC COM - Stock (CBIO) as of Q3 2017

As of 30 Sep 2017, GYRE THERAPEUTICS INC COM - Stock (CBIO) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,254,597 shares. The largest 10 holders included Sio Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, NEA Management Company, LLC, UBS Group AG, Bank of New York Mellon Corp, FNY Partners Fund LP, and FNY Managed Accounts LLC. This page lists 10 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.